Andrea James - Oct 2, 2024 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Chief Financial Officer
Signature
/s/ Andrea James
Stock symbol
OCX
Transactions as of
Oct 2, 2024
Transactions value $
$100,000
Form type
4
Date filed
10/4/2024, 07:40 PM
Previous filing
Jun 24, 2024
Next filing
Oct 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Purchase $100K +33.7K $2.97 33.7K Oct 2, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of October 2, 2024, by and among the Issuer and the investors signatory thereto.